MW1074A1 - Process for preparing 3-fluorocephalosporins - Google Patents

Process for preparing 3-fluorocephalosporins

Info

Publication number
MW1074A1
MW1074A1 MW10/74*UA MW1074A MW1074A1 MW 1074 A1 MW1074 A1 MW 1074A1 MW 1074 A MW1074 A MW 1074A MW 1074 A1 MW1074 A1 MW 1074A1
Authority
MW
MALAWI
Prior art keywords
fluorocephalosporins
preparing
Prior art date
Application number
MW10/74*UA
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of MW1074A1 publication Critical patent/MW1074A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/02Preparation
    • C07D501/04Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
MW10/74*UA 1974-02-06 1974-03-20 Process for preparing 3-fluorocephalosporins MW1074A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US439206A US3926978A (en) 1974-02-06 1974-02-06 Process for preparing 3-fluorocephalosporins

Publications (1)

Publication Number Publication Date
MW1074A1 true MW1074A1 (en) 1975-07-09

Family

ID=23743733

Family Applications (1)

Application Number Title Priority Date Filing Date
MW10/74*UA MW1074A1 (en) 1974-02-06 1974-03-20 Process for preparing 3-fluorocephalosporins

Country Status (32)

Country Link
US (1) US3926978A (no)
JP (1) JPS612678B2 (no)
AR (1) AR202209A1 (no)
AT (1) AT329181B (no)
BE (1) BE813169A (no)
BG (1) BG25091A3 (no)
BR (1) BR7404085A (no)
CA (1) CA1017741A (no)
CH (1) CH598263A5 (no)
DD (1) DD117465A5 (no)
DE (1) DE2417988A1 (no)
DK (1) DK119874A (no)
EG (1) EG11061A (no)
ES (1) ES427235A1 (no)
FI (1) FI99474A (no)
FR (1) FR2259826B1 (no)
GB (1) GB1462944A (no)
GT (1) GT197432532A (no)
HU (1) HU167748B (no)
IE (1) IE38980B1 (no)
IL (1) IL44361A (no)
IN (1) IN139927B (no)
MW (1) MW1074A1 (no)
NL (1) NL7403126A (no)
NO (1) NO741093L (no)
OA (1) OA04641A (no)
PH (1) PH12616A (no)
PL (1) PL90989B1 (no)
RO (1) RO63021A (no)
SE (1) SE411453B (no)
ZA (1) ZA741423B (no)
ZM (1) ZM5674A1 (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4208515A (en) * 1973-02-23 1980-06-17 Eli Lilly And Company 3-Halo cephalosporins
US4064343A (en) * 1974-04-01 1977-12-20 Eli Lilly And Company 3-Halo cephalosporins
US4260745A (en) * 1979-10-12 1981-04-07 Eli Lilly And Company 3-Halo cephalosporins
US4281116A (en) * 1979-10-12 1981-07-28 Eli Lilly And Company 3-Halo cephalosporins
US4252950A (en) * 1979-10-12 1981-02-24 Eli Lilly And Company 3-Halo cephalosporins
DE3851449T2 (de) * 1987-02-27 1995-03-16 Banyu Pharma Co Ltd Cephalosporinderivate, Verfahren zu ihrer Herstellung und antibakterielle Mittel.
JPH0343723A (ja) * 1989-07-11 1991-02-25 Japan Servo Co Ltd 投影器
WO1993011132A1 (de) * 1991-12-06 1993-06-10 Ciba-Geigy Ag Verfahren zur herstellung des antibiotikums cefaclor
IT1255458B (it) * 1992-05-11 1995-11-02 Col Marco Da Procedimento per la preparazione di derivati beta-lattamici alogenati

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3830808A (en) * 1968-06-14 1974-08-20 Glaxo Lab Ltd Cephalosporins having a thioetherified methyl group at the 3-position
GB1377651A (en) * 1971-01-12 1974-12-18 Glaxo Lab Ltd Esters

Also Published As

Publication number Publication date
ES427235A1 (es) 1976-07-16
FI99474A (no) 1975-08-07
IL44361A0 (en) 1974-06-30
DK119874A (no) 1975-09-29
IE38980B1 (en) 1978-07-05
DE2417988A1 (de) 1975-08-07
CA1017741A (en) 1977-09-20
IN139927B (no) 1976-08-21
ATA312174A (de) 1975-07-15
FR2259826A1 (no) 1975-08-29
SE411453B (sv) 1979-12-27
SE7403307L (no) 1975-08-07
GB1462944A (en) 1977-01-26
JPS612678B2 (no) 1986-01-27
AU6640374A (en) 1975-09-11
JPS50108287A (no) 1975-08-26
US3926978A (en) 1975-12-16
AT329181B (de) 1976-04-26
OA04641A (fr) 1980-07-31
GT197432532A (es) 1975-09-25
ZA741423B (en) 1975-10-29
AR202209A1 (es) 1975-05-23
BR7404085A (pt) 1976-01-27
IL44361A (en) 1977-07-31
FR2259826B1 (no) 1977-06-24
IE38980L (en) 1975-08-06
BG25091A3 (en) 1978-07-12
PH12616A (en) 1979-07-05
RO63021A (fr) 1978-05-15
NL7403126A (nl) 1975-08-08
HU167748B (no) 1975-12-25
ZM5674A1 (en) 1977-04-21
EG11061A (en) 1976-11-30
NO741093L (no) 1975-09-01
BE813169A (fr) 1974-10-02
CH598263A5 (no) 1978-04-28
DD117465A5 (no) 1976-01-12
PL90989B1 (no) 1977-02-28

Similar Documents

Publication Publication Date Title
CS183829B2 (en) Process for preparing thienamycine
HU174074B (hu) Sposob poluchenija 4-polialkoksi-fenil-2-pirrolidona
JPS51125466A (en) Process for preparing graftcopolymer
HU171059B (hu) Sposob poluchenija piridazinil-benzimidazolov
YU328375A (en) Process for preparing aryl-imidazolyl-ketones
HU171231B (hu) Sposob poluchenija iodo-polivinilpirrolidona
CS187466B2 (en) Process for preparing 2-arylamino-2-imidazolines
YU45275A (en) Process for preparing basic alumonium oxycarbonate-hydrate
CS189730B2 (en) Process for preparing o-cyanazodyes
CS191290B2 (en) Process for preparing aminoalkylphenyletheres
HU175380B (hu) Sposob poluchenija tiolkarbamatov
CS193518B2 (en) Process for preparing moenomycine
ZM5674A1 (en) Process for preparing 3-fluorocephalosporins
CS188259B2 (en) Process for preparing 2-anilinooxazoles
CS188984B2 (en) Process for preparing 3-fluorbenzodiazepines
GB1486844A (en) Process for preparing 7beta-acylamino-7alpha-alkoxy-cephalosporins
HU175228B (hu) Sposob poluchenija 6-metil-8beta-nitrometil-ehrgolina
HU172658B (hu) Sposob poluchenija benzol-sul'fonil-karbamidov
HU172273B (hu) Sposob poluchenija 2-dejtero-3-ftor-dl-alanina
JPS51125257A (en) Process for preparing 111deoxyy omegaapentanolprostagladine
CS188967B2 (en) Process for preparing 6-chlor-2-chlormethyl-4-phenylquinazolin-3-oxide
CS191291B2 (en) Process for preparing 3-methylencepham-sulphoxides
CS188253B2 (en) Process for preparing 2-methyl-3-hydroxy-4-ethylaminomethyl-5-methylmercaptomethyl-pyridine
CS193511B2 (en) Process for preparing dihydroxy-benzenes
CS185239B2 (en) Process for preparing dichloracetylchloride